Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2004 | 1 |
2005 | 1 |
2006 | 1 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Anti-tumor immunity influences cancer cell reliance upon ATG7.
Oncoimmunology. 2020 Aug 23;9(1):1800162. doi: 10.1080/2162402X.2020.1800162.
Oncoimmunology. 2020.
PMID: 32923161
Free PMC article.
Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity.
Arensman MD, Yang XS, Leahy DM, Toral-Barza L, Mileski M, Rosfjord EC, Wang F, Deng S, Myers JS, Abraham RT, Eng CH.
Arensman MD, et al. Among authors: rosfjord ec.
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9533-9542. doi: 10.1073/pnas.1814932116. Epub 2019 Apr 24.
Proc Natl Acad Sci U S A. 2019.
PMID: 31019077
Free PMC article.
Item in Clipboard
Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2).
Wissner A, Overbeek E, Reich MF, Floyd MB, Johnson BD, Mamuya N, Rosfjord EC, Discafani C, Davis R, Shi X, Rabindran SK, Gruber BC, Ye F, Hallett WA, Nilakantan R, Shen R, Wang YF, Greenberger LM, Tsou HR.
Wissner A, et al. Among authors: rosfjord ec.
J Med Chem. 2003 Jan 2;46(1):49-63. doi: 10.1021/jm020241c.
J Med Chem. 2003.
PMID: 12502359
Item in Clipboard
Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M, Bott MJ, Khandke N, McGinnis JP, Miranda M, Meyyappan M, Rosfjord EC, Rabindran SK.
Grillo M, et al. Among authors: rosfjord ec.
Breast Cancer Res Treat. 2006 Jan;95(2):185-94. doi: 10.1007/s10549-005-9066-y. Epub 2005 Dec 1.
Breast Cancer Res Treat. 2006.
PMID: 16319987
Item in Clipboard
Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase.
Rabindran SK, Discafani CM, Rosfjord EC, Baxter M, Floyd MB, Golas J, Hallett WA, Johnson BD, Nilakantan R, Overbeek E, Reich MF, Shen R, Shi X, Tsou HR, Wang YF, Wissner A.
Rabindran SK, et al. Among authors: rosfjord ec.
Cancer Res. 2004 Jun 1;64(11):3958-65. doi: 10.1158/0008-5472.CAN-03-2868.
Cancer Res. 2004.
PMID: 15173008
Item in Clipboard
Cite
Cite